NEW YORK (360Dx) – T2 Biosystems announced yesterday that it expects its fourth quarter revenues to exceed its prior guidance  between $1.1 million and $1.3 million. The consensus Wall Street revenue estimate for the recently completed quarter is $1.2 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.